维普中文期刊产品整合服务
18篇 您的检索式:作者名="Taura N"
    题名 作者 年代 出处 被引量
1NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival:a preliminary evaluation of an improved assay for PIVKA-Ⅱ显示文摘Nanashima A Abo T Taura N 2013Anticancer Res2013,33,6:1
2CHOP deficiency attenuatescholestasis-induced liver fibrosis by reduction of hepatocyteinjury显示文摘Tamaki N Hatano E Taura K 2008Am J Physiol Gastrointest Liver Physiol2008,294,2:1
3Diffuse liver melastasis of small cell lung eaneer causing marked hepatomegaly and fulmi- nant hepalie failure 显示文摘Miyaaki H Iehikawa T Taura N 2010Intern Med2010,49,14:1
4Differences inprognostic factors according to viral status in patientswith hepatocellular carcinoma显示文摘Akahoshi H Taura N Ichikawa T 2010Oncol Rep2010,23,5:1
5CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury 显示文摘Tamaki N Hatano E Taura K 2008Am J Physiol Gastrointest Liver Physiol2008,294,2:1
6CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury 显示文摘Tamaki N Hatano E Taura K 2008Am J Physiol Gastrointest LiverPhysiol2008,294,2:1
7Tumor marker levels before and after Curative treatment of hepatocellular carcinoma as predictors of patient survival显示文摘Nanashima A Taura N Abo T 2011Dig Dis Sci2011,56,:1
8Clinical benefits of hepatocellular carcinoma surveillance:a single-center,hospital-based study显示文摘Taura N Hamasaki K Nakao K 0,,:1
9Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma显示文摘Akahoshi H Taura N Ichikawa T 2010Oncol Rep2010,23,5:1
10Frequency of elevatedbiomarkers in patients with cryptogenic hepatocellular carcinoma显示文摘Taura N Ichikawa T Miyaaki H 2013Med Sci Monit2013,19,:1
11An early phase Ⅱ study of a 3 - hour infusion of paclitaxel for advanced gastric cancer 显示文摘Obtsu A Boku N Taura F 1998Am J Clin Oncol1998,21,4:1
12Diffuse liver metastasis of small cell lung cancer causing marked hepatomegaly and fulminant hepatic failure显示文摘Miyaaki H Ichikawa T Taura N 2010Intern Med2010,49,14:1
13Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma显示文摘Akahoshi H Taura N Ichikawa T 2010Oncol Rep2010,23,5:1
14CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury显示文摘Tamaki N Hatano E Taura K Tada M Kodama Y Nitta T 2008Am J Physiol Gastrointest Liver Physiol2008,294,2:1
15CHOP deficiency attenu- ates eholestasis-induced liver fibrosis by reduction of hepatocyteinjury显示文摘Tamaki N Hatano E Taura K 2008Am J Physiol Gastrointest Liver Physiol2008,294,2:1
16CHOP deficiency at- tenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury 显示文摘Tamaki N Hatano E Taura K 2008Am J Physiol Gastrointest Liver Physiol2008,294,2:1
17Diffuse liver metastasis of small cell lung cancer causing marked hepatomegaly and fulminant hepatic failure显示文摘Miyaaki H Ichikawa T Taura N 2010Intern Med2010,49,14:1
18CHOP deficiency attenu- ates eholestasis - induced liver fibrosis by reduction of hepatocyte injury显示文摘Tamaki N Hatano E Taura K 2008Am J Physiol Gastrointest Liver Physiol2008,294,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费